181 related articles for article (PubMed ID: 15630586)
1. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
[TBL] [Abstract][Full Text] [Related]
3. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of 123I-IMT SPECT in the follow-up of head and neck cancer.
Plotkin M; Wurm R; Kuczer D; Wust P; Michel R; Denecke T; Ruf J; Schlenger L; Bischoff A; Felix R; Amthauer H
Onkologie; 2006 Apr; 29(4):147-52. PubMed ID: 16601370
[TBL] [Abstract][Full Text] [Related]
6. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.
Grosu AL; Feldmann H; Dick S; Dzewas B; Nieder C; Gumprecht H; Frank A; Schwaiger M; Molls M; Weber WA
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):842-54. PubMed ID: 12377338
[TBL] [Abstract][Full Text] [Related]
7. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
[TBL] [Abstract][Full Text] [Related]
8. [The role of L-3-I-123-iodine-alpha-methyltyrosine SPECT in cerebral gliomas].
Weckesser M; Schmidt D; Matheja P; Coenen HH; Langen KJ
Nuklearmedizin; 2000 Dec; 39(8):233-40. PubMed ID: 11189900
[TBL] [Abstract][Full Text] [Related]
9. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
[TBL] [Abstract][Full Text] [Related]
11. Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.
Caresia AP; Castell-Conesa J; Negre M; Mestre A; Cuberas G; Mañes A; Maldonado X
Clin Transl Oncol; 2006 Oct; 8(10):750-4. PubMed ID: 17074674
[TBL] [Abstract][Full Text] [Related]
12. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas.
Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the extension of cerebral gliomas by scintigraphy.
Weckesser M; Matheja P; Rickert C; Löttgen J; Palkovic S; Riemann B; Paulus W; Wassmann H; Schober O
Strahlenther Onkol; 2000 Apr; 176(4):180-5. PubMed ID: 10812391
[TBL] [Abstract][Full Text] [Related]
14. Combined SPECT/CT imaging using 123I-IMT in the detection of recurrent or persistent head and neck cancer.
Plotkin M; Wurm R; Eisenacher J; Szerewicz K; Michel R; Schlenger L; Pech M; Denecke T; Kuczer D; Bischoff A; Felix R; Amthauer H
Eur Radiol; 2006 Feb; 16(2):503-11. PubMed ID: 15983775
[TBL] [Abstract][Full Text] [Related]
15. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ
J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676
[TBL] [Abstract][Full Text] [Related]
16. I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours.
Matheja P; Weckesser M; Rickert Ch; Franzius Ch; Palkovic S; Riemann B; Schober O
Nuklearmedizin; 2002; 41(4):191-6. PubMed ID: 12224403
[TBL] [Abstract][Full Text] [Related]
17. Relevance of image fusion with MRI for the interpretation of I-123 iodo-methyl-tyrosine scans in patients with suspected recurrent or residual brain tumor.
Amthauer H; Wurm R; Kuczer D; Ruf J; Michel R; Eisenacher J; Stockhammer F; Denecke T; Felix R; Plotkin M
Clin Nucl Med; 2006 Apr; 31(4):189-92. PubMed ID: 16550008
[TBL] [Abstract][Full Text] [Related]
18. Sequential scintigraphic strategy for the differentiation of brain tumours.
Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
[TBL] [Abstract][Full Text] [Related]
19. 123I-IMT SPECT for evaluation of the response to radiation therapy in high grade gliomas: a feasibility study.
Kuczer D; Feussner A; Wurm R; Wust P; Michel R; Stockhammer F; Denecke T; Amthauer H; Felix R; Plotkin M
Br J Radiol; 2007 Apr; 80(952):274-8. PubMed ID: 17121760
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
